From: Harnessing genomics to improve health in the Eastern Mediterranean Region – an executive course in genomics policy
Bhutta ZA (2002) Ethics in international health research: a perspective from the developing world.
Bull World Health Organ.;80(2):114–20. Review.
Bloom BR & Trach D (2001) Genetics and Developing Countries. BMJ;322:1006–7.
Capron AM (2001) Stem Cells: Ethics, Law and Politics. Biotech Law Report;5:678–699.
Collins FS, Green ED, Guttmacher AE, Guyer MS; US National Human Genome Research Institute. (2003) A vision for the future of genomics research.
Daar AS, Thorsteinsdóttir H, Martin DK, Smith AC, Nast S, Singer PA. (2002) Top ten biotechnologies for improving health in developing countries. Nat Genet.;32(2):229–32.
Gold ER (2003) SARS genome patent: symptom or disease? Lancet.;361(9374):2002–3.
Juma C & Konde V (2002). The New Bioeconomy: Industrial and Environmental Biotechnology in Developing Countries. Geneva, Switzerland: United Nations, July 2002.
Lundvall B, Johnson B, Andersen EA, Dalum B (2002) National systems of production, innovation and competence building. Research Policy;31:213–231
Nasim A (2000) Ethical Issues of the Human Genome Project: An Islamic Perspective in Bioethics in Asia. Eubios Ethics Institute Eds: N Fujiki and DRJ Macer p. 209–214
Pang T & Weatherall D (2002) Genomics and Global Health. BMJ;324:p.1051–52
Singer PA, Daar AS (2001) Harnessing genomics and biotechnology to improve global health equity. Science;294(5540):87–9.
Sulston J (2003) Beyond release: the equitable use of genomic information.
Thorsteinsdóttir H, Daar AS, Smith RD, Singer PA (2003) Genomics – a global public good?
Time to Unite Islam and Science. Nature. 2003 Mar 13;422(6928):99.